2023年全球制藥(yao)公司排行榜顯(xian)示,上(shang)榜50強藥(yao)企(qi)2022年度銷售(shou)總額為8941.42億美元,同比(bi)(bi)上(shang)年增加(jia)了382.46億美元。50強企(qi)業入(ru)圍門檻為15.55億美元,同比(bi)(bi)上(shang)年降低(di)了14.04億美元。
從(cong)銷(xiao)(xiao)售額(e)(e)規模來看,2023年全(quan)球藥企(qi)50強名單中有(you)(you)4家企(qi)業(ye)銷(xiao)(xiao)售額(e)(e)突(tu)破500億(yi)美元(yuan),有(you)(you)18家企(qi)業(ye)銷(xiao)(xiao)售額(e)(e)在100-500億(yi)美元(yuan)之(zhi)間,有(you)(you)12家企(qi)業(ye)銷(xiao)(xiao)售額(e)(e)在50-100億(yi)美元(yuan)之(zhi)間,其余16家企(qi)業(ye)銷(xiao)(xiao)售額(e)(e)在50億(yi)美元(yuan)以(yi)下。
中國方面,2023年中國共計(ji)有四家藥(yao)企上(shang)榜,分別是中國生(sheng)物(wu)制藥(yao)(39名(ming))、上(shang)海醫藥(yao)(41名(ming))、江蘇恒瑞醫藥(yao)(43名(ming))、石(shi)藥(yao)集團(48名(ming))。
排行 | 藥企 | 2022銷售額(億美元) | 2022研發費用(億美元) |
1 | Pfizer | 913.03 | 123.81 |
2 | AbbVie | 561.79 | 64.35 |
3 | Johnson & Johnson | 501.79 | 141.40 |
4 | Novartis | 500.79 | 90.88 |
5 | Merck & Co. | 496.27 | 118.42 |
6 | Roche | 479.09 | 147.81 |
7 | Bristol Myers Squibb | 454.17 | 100.16 |
8 | AstraZeneca | 429.98 | 95.00 |
9 | Sanofi | 403.53 | 71.56 |
10 | GSK | 382.54 | 63.37 |
11 | Takeda | 296.90 | 46.97 |
12 | Gilead Sciences | 266.15 | 49.68 |
13 | Eli Lilly | 254.63 | 71.91 |
14 | Novo Nordisk | 253.84 | 34.50 |
15 | Amgen | 225.36 | 43.41 |
16 | Boehringer Ingelheim | 194.73 | 53.86 |
17 | Bayer | 188.98 | 70.13 |
18 | Moderna | 184.35 | 29.93 |
19 | Viatris | 159.99 | 6.98 |
20 | CSL | 131.23 | 13.47 |
21 | Teva Pharmaceutical Industries | 120.71 | 8.38 |
22 | Astellas Pharma | 105.11 | 20.11 |
23 | Vertex Pharmaceuticals | 86.07 | 21.04 |
24 | Merck KGaA | 83.66 | 26.90 |
25 | Biogen | 79.88 | 22.31 |
26 | Otsuka Holdings | 73.57 | 21.46 |
27 | Daiichi Sankyo | 70.89 | 23.14 |
28 | Regeneron Pharmaceuticals | 68.94 | 38.31 |
29 | Bausch Health Companies | 65.69 | 5.29 |
30 | Organon | 60.38 | 5.22 |
31 | UCB | 56.63 | 17.82 |
32 | Perrigo Company | 54.36 | 1.25 |
33 | Sun Pharmaceutical Industries | 54.24 | 2.94 |
34 | Les Laboratoires Servier | 51.93 | N/A |
35 | Chugai Pharmaceutical | 11.20 | 11.20 |
36 | Abbott Laboratories | 48.85 | 26.06 |
37 | Grifols | 48.64 | 4.25 |
38 | Eisai | 45.96 | 12.28 |
39 | Sino Biopharmaceutical | 44.63 | 6.01 |
40 | Fresenius | 43.42 | 9.25 |
41 | Shanghai Pharmaceuticals Holding | 40.43 | 2.61 |
42 | Horizon Therapeutics | 40.22 | 4.77 |
43 | Jiangsu Hengrui Medicine | 40.10 | 8.93 |
44 | Jazz Pharmaceuticals | 36.34 | 6.10 |
45 | Menarini | 36.21 | N/A |
46 | Ipsen | 34.47 | 4.90 |
47 | BioNTech | 33.39 | 16.40 |
48 | CSPC Pharmaceutical Group | 33.34 | 5.11 |
49 | Incyte | 37.47 | 14.57 |
50 | Novavax | 15.55 | 12.35 |
PharmExec(美國制藥(yao)經理人雜志)公布了(le)“2022年全球制藥(yao)企業(ye)TOP50榜單(dan)”。榜...
中(zhong)國(guo)董(dong)事(shi)局網與(yu)中(zhong)國(guo)數(shu)據研究中(zhong)心(xin)共同發(fa)布(bu)了“2022第八(ba)屆(jie)中(zhong)國(guo)最具影(ying)響(xiang)力醫藥企(qi)業(ye)百強榜(bang)”。榜(bang)...
E藥經理人發(fa)布了“2022中國(guo)醫藥創新企業100強榜(bang)單”。榜(bang)單以授(shou)權(quan)專(zhuan)利數(shu)量、專(zhuan)利施引總量...
米(mi)內網公(gong)布了“2021-2022年度中國連鎖藥店綜合實力(li)百強(qiang)、直營力(li)百強(qiang)兩份(fen)榜單”。榜單從...